CAMBRIDGE, Mass., Oct. 10, 2017 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 2017
BIO Investor Forum on Tuesday, October 17,
2017, at 10:45 a.m. PT
(1:45 p.m. ET) in San Francisco, CA. A live webcast of
Infinity's presentation will be accessible on the Investors/Media
section of Infinity's website at www.infi.com, and will be
available for 30 days following the event.
About Infinity
Infinity is an innovative
biopharmaceutical company dedicated to advancing novel medicines
for people with cancer. Infinity is advancing IPI-549, an oral
immuno-oncology development candidate that selectively inhibits
PI3K-gamma. A Phase 1 study in patients with advanced solid tumors
is ongoing. For more information on Infinity, please refer to
Infinity's website at www.infi.com.
Contact:
Jaren Irene
Madden, Senior Director,
Investor Relations and Corporate Communications
617-453-1336 or Jaren.Madden@infi.com
View original
content:http://www.prnewswire.com/news-releases/infinity-to-present-at-the-2017-bio-investor-forum-300532737.html
SOURCE Infinity Pharmaceuticals, Inc.